![Absolute change in forced expiratory volume in 1 s (FEV1) % pred over time in clinical trials with a) ivacaftor (IVA) in patients with at least one G551D. - ppt download Absolute change in forced expiratory volume in 1 s (FEV1) % pred over time in clinical trials with a) ivacaftor (IVA) in patients with at least one G551D. - ppt download](https://slideplayer.com/17483899/102/images/slide_1.jpg)
Absolute change in forced expiratory volume in 1 s (FEV1) % pred over time in clinical trials with a) ivacaftor (IVA) in patients with at least one G551D. - ppt download
![Leitlinie der Deutschen Atemwegsliga, der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin und der Deutschen Gesellschaft für Arbeitsmedizin und Umweltmedizin zur Spirometrie - Leitlinie zur Spirometrie - ASU Leitlinie der Deutschen Atemwegsliga, der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin und der Deutschen Gesellschaft für Arbeitsmedizin und Umweltmedizin zur Spirometrie - Leitlinie zur Spirometrie - ASU](https://www.asu-arbeitsmedizin.com/sites/default/files/styles/discover/public/ulmer/de-asu/image/binarydata_original_640014.jpg?itok=Ihr3LUH3)
Leitlinie der Deutschen Atemwegsliga, der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin und der Deutschen Gesellschaft für Arbeitsmedizin und Umweltmedizin zur Spirometrie - Leitlinie zur Spirometrie - ASU
![Figure 7, KQ1 pulmonary function—meta-analysis of change from baseline in absolute FEV1 in CF patients treated with rhGH - Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients With Figure 7, KQ1 pulmonary function—meta-analysis of change from baseline in absolute FEV1 in CF patients treated with rhGH - Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients With](https://www.ncbi.nlm.nih.gov/books/NBK61949/bin/ch3f6.jpg)
Figure 7, KQ1 pulmonary function—meta-analysis of change from baseline in absolute FEV1 in CF patients treated with rhGH - Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients With
![Figure 2, Between-Treatment Differences for Absolute Change in Per cent Predicted FEV1 for IVA Versus PL - Ivacaftor (Kalydeco) 150 mg Tablet - NCBI Bookshelf Figure 2, Between-Treatment Differences for Absolute Change in Per cent Predicted FEV1 for IVA Versus PL - Ivacaftor (Kalydeco) 150 mg Tablet - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK349129/bin/sr0379f2.jpg)
Figure 2, Between-Treatment Differences for Absolute Change in Per cent Predicted FEV1 for IVA Versus PL - Ivacaftor (Kalydeco) 150 mg Tablet - NCBI Bookshelf
![Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients | npj Primary Care Respiratory Medicine Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41533-017-0064-4/MediaObjects/41533_2017_64_Fig1_HTML.jpg)
Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients | npj Primary Care Respiratory Medicine
![Absolute change in forced expiratory volume in 1 s (FEV1) in ml after... | Download Scientific Diagram Absolute change in forced expiratory volume in 1 s (FEV1) in ml after... | Download Scientific Diagram](https://www.researchgate.net/publication/224868507/figure/fig10/AS:316793232085003@1452540800659/Absolute-change-in-forced-expiratory-volume-in-1-s-FEV1-in-ml-after-bronchodilator.png)
Absolute change in forced expiratory volume in 1 s (FEV1) in ml after... | Download Scientific Diagram
![FEV1 recovery following methacholine challenge in asthma: Variability and comparison of methods - ScienceDirect FEV1 recovery following methacholine challenge in asthma: Variability and comparison of methods - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1094553919303037-gr2.jpg)
FEV1 recovery following methacholine challenge in asthma: Variability and comparison of methods - ScienceDirect
Spirometrie in der Praxis Workshop (Modul für MPA: Lungen- und Atemwegserkrankungen / Pneumologie) 18. Februar 2015, Bern
![GOLD criteria overestimate airflow limitation in one-third of cases in the general Finnish population | European Respiratory Society GOLD criteria overestimate airflow limitation in one-third of cases in the general Finnish population | European Respiratory Society](https://openres.ersjournals.com/content/erjor/2/4/00084-2015/F1.large.jpg)
GOLD criteria overestimate airflow limitation in one-third of cases in the general Finnish population | European Respiratory Society
![Annual change in FEV1 in elderly 10-year survivors with established chronic obstructive pulmonary disease | Scientific Reports Annual change in FEV1 in elderly 10-year survivors with established chronic obstructive pulmonary disease | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-38659-8/MediaObjects/41598_2019_38659_Fig3_HTML.png)
Annual change in FEV1 in elderly 10-year survivors with established chronic obstructive pulmonary disease | Scientific Reports
![Office‐based spirometry for early detection of obstructive lung disease - Wallace - 2006 - Journal of the American Academy of Nurse Practitioners - Wiley Online Library Office‐based spirometry for early detection of obstructive lung disease - Wallace - 2006 - Journal of the American Academy of Nurse Practitioners - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e4a5be60-ce68-4d68-a365-12189cdacd06/jaan_149_f4.gif)